Immunotherapy before surgery boosts survival for for liver cancer patients, clinical research finds
Immune checkpoint inhibitor (ICI) therapy before surgery for hepatocellular carcinoma (HCC) may produce major pathological response in about one-third of the surgical patients. The clinical and pre-clinical research highlighted ...
22 hours ago
0
0









